CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes

被引:313
作者
Nelson, Brad H. [1 ,2 ,3 ]
机构
[1] British Columbia Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC V8R 6V5, Canada
[2] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada
[3] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada
关键词
KIDNEY-TRANSPLANT REJECTION; RENAL-ALLOGRAFT REJECTION; MEDULLARY BREAST-CANCER; T-CELLS; LUNG-CANCER; IMMUNE-RESPONSES; PROSTATE-CANCER; DENDRITIC CELLS; SYSTEMIC AUTOIMMUNITY; RHEUMATOID-ARTHRITIS;
D O I
10.4049/jimmunol.1001323
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tumor-infiltrating CD8(+) T cells are strongly associated with patient survival in a wide variety of human cancers. Less is known about tumor-infiltrating CD20(+) B cells, which often colocalize with T cells, sometimes forming organized lymphoid structures. In autoimmunity and organ transplantation, T cells and B cells collaborate to generate potent, unrelenting immune responses that can result in extensive tissue damage and organ rejection. In these settings, B cells enhance T cell responses by producing Abs, stimulatory cytokines, and chemokines, serving as local APCs, and organizing the formation of tertiary lymphoid structures that sustain long-term immunity. Thus, B cells are an important component of immunological circuits associated with persistent, rampant tissue destruction. Engagement of tumor-reactive B cells may be an important condition for generating potent, long-term T cell responses against cancer. The Journal of Immunology, 2010, 185: 4977-4982.
引用
收藏
页码:4977 / 4982
页数:6
相关论文
共 95 条
[41]   In Vivo Sensitized and In Vitro Activated B Cells Mediate Tumor Regression in Cancer Adoptive Immunotherapy [J].
Li, Qiao ;
Teitz-Tennenbaum, Seagal ;
Donald, Elizabeth J. ;
Li, Mu ;
Chang, Alfred E. .
JOURNAL OF IMMUNOLOGY, 2009, 183 (05) :3195-3203
[42]  
Lim Kok Haw Jonathan, 2010, Cancer Immun, V10, P3
[43]   Rituximab-induced B cell depletion in autoimmune diseases: Potential effects on T cells [J].
Liossis, Stamatis-Nick C. ;
Sfikakis, Petros P. .
CLINICAL IMMUNOLOGY, 2008, 127 (03) :280-285
[44]   Cytokine-producing B lymphocytes - key regulators of immunity [J].
Lund, Frances E. .
CURRENT OPINION IN IMMUNOLOGY, 2008, 20 (03) :332-338
[45]  
LUNDY SK, 2009, INFLAMM RES IN PRESS
[46]   Computerised counting of tumour infiltrating lymphocytes in 90 breast cancer specimens [J].
Marsigliante, S ;
Biscozzo, L ;
Marra, A ;
Nicolardi, G ;
Leo, G ;
Lobreglio, GB ;
Storelli, C .
CANCER LETTERS, 1999, 139 (01) :33-41
[47]   B cell immunobiology in disease: Evolving concepts from the clinic [J].
Martin, Flavius ;
Chan, Andrew C. .
ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 :467-496
[48]   Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs [J].
McGill, Jodi ;
Van Rooijen, Nico ;
Legge, Kevin L. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (07) :1635-1646
[49]   Differential expression of RANTES chemokine, TGF-β, and leukocyte phenotype in acute cellular rejection and Quilty B lesions [J].
Michaels, PJ ;
Kobashigawa, J ;
Laks, H ;
Azarbal, A ;
Espejo, ML ;
Chen, L ;
Fishbein, MC .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2001, 20 (04) :407-416
[50]   Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors [J].
Milne, Katy ;
Koebel, Martin ;
Kalloger, Steven E. ;
Barnes, Rebecca O. ;
Gao, Dongxia ;
Gilks, C. Blake ;
Watson, Peter H. ;
Nelson, Brad H. .
PLOS ONE, 2009, 4 (07)